Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Vilon structure

Vilon

Immune
Phase 1 Research
25%
Low Risk
1/5

Dosing Protocol

Typical Dose 10 mg
Range 10 - 20 mg
Loading Phase 20 mg × 10 days
Maintenance 10 mg daily
Cycle 2w on / 24w off

Pharmacokinetics

Half-Life 30 min
Onset 15 min
Peak 1.0 hrs
Duration 4.0 hrs
Bioavailability 50%
Primary Route Oral

Administration

Routes Oral, Subcutaneous
Injection Sites Abdomen
Needle Gauge 29-31G
Syringe Type Oral
Timing Morning, Fasted

Special Instructions

Smallest bioactive peptide (2 amino acids). Often combined with Thymalin for immune support. Khavinson bioregulator. Used in 10-20 day courses with long breaks.